FP7 logo euThe SATURN project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n°241796

Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria

Presentations in conferences

2015

Adler Amos, Geffen Yuval, Ben-Dalak Ma'ayan, Gorenshtein Sofia, Gutkovich Nadya, Weinberg Gila, Zuntz Meirav, Carmeli Yehuda, Assous Marc Victor "Spread of a new KPC-producing species, Citrobacter maimonidesii sp. nov., in six patients from two medical centres in Israel". ECCMID, 2015, Copenhagen, Denmark, 27 April 2015. Poster P1065

Marí Marta, Rolo Dora, Mosqueda Noraida, van Duijn Pleun J, Bonten Marc, Harbarth Stephan, Roca Ignasi, Vila Jordi "Characterization of multidrug-resistant Pseudomonas aeruginosa isolates from intensive care unit patients from five European countries". ECCMID, 2015, Copenhagen, Denmark, 26 April 2015. Poster P0316

Marasca Giuseppe, Schröder Wiebke, Tacconelli Evelina, Gorska Anna "Selection of antibiotic-resistant bacteria is a predictable, severe, adverse drug event of the most used antibiotics in hospitalized patients". ECCMID, 2015, Copenhagen, Denmark, 25 April 2015. Oral presentation O001

2014

Harbarth S "Optimizing Antibiotic Therapy - The Challenge of Resistance". International Sepsis Forum 2014, Paris, France, 3-5 December 2014. Oral presentation of December 3, 2014.

Adler A, Hussein O, Ben David D, Masarwa S, Schwaber MJ, and Carmeli Y "Persistence of the Klebsiella pneumoniae Sequence Type 258 as the Predominant Clone of Carbapenemase-Producing Enterobacteriaceae in Post-Acute Care Facilities in Israel, 2008-2013". ID Week, 2014, Philadelphia, USA, 8-12 October 2014. Poster Abstract Session "Multidrug-resistant Organisms: Epidemiology and Prevention" of October 9, 2014.

Mosqueda N, Roca I, Altun B, Espinal P, Akova M, Vila J "Molecular characterisation of blaNDM-1 in an Acinetobacter pittii strain isolated from Turkey in 2006". ECCMID, 2014, Barcelona, Spain, 12 May 2014. Poster P1192

Adler A, Miller-Roll T, Assous MV, Gefen Y, Paikin S, Schwartz D, Wiener-Well Y, Hussein K, Cohen R, Carmeli Y "A multicentre study of the clonal structure and resistance mechanism of KPC-producing E. coli isolates in Israel". ECCMID, 2014, Barcelona, Spain, 12 May 2014. Poster 1172.

Khabra E, Adler A, Paikin S, Carmeli Y "The tale of two outbreaks: mono- vs. multispecies colonisation by KPC-producing Enterobacteriaceae". ECCMID, 2014, Barcelona, Spain, 12 May 2014. Oral session 142

Francois P, De Angelis G, Schroeder W, Restuccia G, Bonetti EJ, Schrenzel J, Tacconelli E "Genotypic diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains colonising and infecting patients in a large multinational prospective cohort study". ECCMID, 2014, Barcelona, Spain, 12 May 2014. Oral session 180

Espinal P, Rolo D, Telli M, Mosqueda N, Roca I, Vila J "Relationship between resistance mechanisms and virulence in a NDM-1-producing-Acinetobacter pittii-like strain using the Caenorhabditis elegans model". ECCMID, 2014, Barcelona, Spain, 10 May 2014. Poster P0180

2013

Solé M, Cobos-Trigueros N, Zamorano L, Fàbrega A, Reustle A, Oliver A, Martínez JA, Vila J " Evolution of resistance in Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: Investigation of the mechanisms of resistance". ICAAC, 2013, Denver, Colorado, USA, 10-13 September 2013. 10 Sep poster session C2-1609b

van den Bijllaardt W, Melchers RJ, van der Velden LB, Cohen-Stuart J, Nabuurs-Franssen MH, Muller AE, Mouton JW "A New Integrated Microdilution Susceptibility Testing Method For Detection And Confirmation of ESBL’s in Routine Clinical Laboratories". ICAAC, 2013, Denver, Colorado, USA, 10-13 September 2013. D-594

Malhotra-Kumar S,Vervoort J, Coenen S, Lammens C, Stewardson A, Godycki-Cwirko M, Harbarths, Gutmann L, Goossens H on behalf of Saturn study group "Impact of Ciprofloxacin (CIP) Therapy on Oral Streptococci (STR) of Patients with Upper Urinary Tract Infections (UTI)". ICAAC, 2013, Denver, Colorado, USA, 10-13 September 2013. C2-546.

Adler A, Assous M, Paikin S, Shulman A, Hillel S,Aronov R, Carmeli Y, Schwaber M "Emergence of VIM-producing Aeromonas caviae in Israeli hospitals". ID Week, San Francisco (USA). 2-6 September 2013. Poster 1621.

Muller AE, Punt N, Mouton JW "%fT>MIC Predicts Probability of Clinical Outcome in the Treatment of Nosocomial Pneumonia by Ceftobiprole". ECCMID 2013, Berlin, Germany, 27-30 April 2013. Poster session P904, 27 April 2013.

2012

Muller AE, Schmitt-Hoffmann AH, Punt N, Mouton JW "Monte Carlo Simulations Based on Phase 1 Studies Predict Target Attainment of Ceftobiprole in Nosocomial Pneumonia Patients: a Validation Study". 52nd ICAAC, San Francisco, USA, 9-12 September 2012. A-624a.

Muller AE, Punt N, Mouton JW "%fT>MIC Predicts Probability of Microbiological Outcome in the Treatment of Nosocomial Pneumonia by Ceftobiprole". 52nd ICAAC, San Francisco, USA, 9-12 September 2012. A-624.

Adler A, Paikin S, Sterlin Y, Glick J, Edgar R, Aronov R, Schwaber MJ, Carmeli Y "A Swordless Knight: the epidemiology and molecular characteristics of the blaKPC-negative sequence-type 258 Klebsiella pneumoniae clone". 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 31.03.2012 - 03.04.2012.

Feldman N, Adler A, Molshatzki N, Navon-Venezia S, Khabra E, Cohen D, Carmeli Y "Gastrointestinal Colonization by KPC-Producing Klebsiella pneumoniae Following Hospital Discharge: Duration of Carriage and Risk Factors for Persistent Carriage". 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 31.03.2012 - 03.04.2012. 03 April 2012, Abstract (oral session-O624), KPC beta-lactamases.

Tacconelli E, Restuccia G, De Angelis G, Palazzolo C, Lammens C, Donato C, Malhotra-Kumar S, Carmeli Y, Schrenzel J, Goossens H "Colonisation by Multidrug resistant gram-negative (MDR-Gn) bacteria surpasses methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission. Is it time to rethink infection control measures in non-ICU patients?". 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 31.03.2012 - 03.04.2012. 31 March 2012, Abstract (oral session-O119), Infection control measures to contain multidrug-resistant Gram-negative bacteria.

2011

Gazin M, Vervoort J, Bryssinck L, Lammens C, Gniadkowski M, Goossens H, Malhotra-Kumar S on behalf of the MOSAR WP2 and SATURN WP1 study groups "Evaluation of a commercial miniaturized DNA microarray for detection of β-lactamase genes in Gram-negative bacteria". ECCMID, Milan, Italy. 7 May 2011. Saturday, May 07, 2011, 15:30 - 16:30. Molecular detection of antibiotic resistance among Gram-negative bacteria.

Vervoort J, Gazin M, Kazma M, Kotlovsky T, Lammens C, Carmeli Y, Goossens H, Malhotra-Kumar S on behalf of the SATURN WP1 and MOSAR WP2 study groups "Alarming rates of fluoroquinolone resistance in blaCTX-M-15 harbouring Enterobacteriaceae recovered from patients with hospital-associated diarrhea". 21st ECCMID-27th ICC. Milan, Italy, 7-10 May 2011. Abstract number: P667.

Vervoort J, Gazin M, Lammens C, Kazma M, Carmeli Y, Gniadkowski M, Goossens H, Malhotra-Kumar S on behalf of the SATURN WP1 and MOSAR WP2 study groups "Characterization of two novel CTX-M-25 group extendedspectrum β-lactamases, CTX-M-94 and -100, recovered from patients at a tertiary care hospital in Israel". NVvM 2011, Arnhem, The Netherlands. 18 April 2011.

Top ^